Gentical Raises $23.7M From Wellington, EdRIP, InnoBio, Others

By Mark Boslet — 3 years ago

Wellington Partners said it is the lead investor in a $23.7 million Series C financing round for Genticel which was closed this week. Wellington Partners committed about $5 million and the remaining came from existing shareholders, including EdRIP, IDInvest, InnoBio, IRDI and Amundi. The funds will be used primarily to finance a phase II program for the Toulouse, France-based HPV- vaccine developer’s lead product ProCervix.

Continue

Wellington Leads Genticel Financing

By Angela Sormani — 3 years ago

Wellington Partners has led a 18.2 million euros series C financing round at Toulouse/France-based therapeutic HPV- vaccine developer Genticel. Wellington Partners committed 4 million euros to this financing. The remaining 14.2 million euros were provided by the existing shareholders including EdRIP, IDInvest, InnoBio, IRDI and Amundi.

Continue